Sort by

Send to

Choose Destination

Search results

Items: 4


Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety.

Pinheiro SP, Rivera DR, Graham DJ, Freedman AN, Major JM, Penberthy L, Levenson M, Bradley MC, Wong HL, Ouellet-Hellstrom R.

Ann Epidemiol. 2016 Aug 31. pii: S1047-2797(16)30276-9. doi: 10.1016/j.annepidem.2016.04.012.


Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses.

Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN.

Ann Oncol. 2014 Jan;25(1):16-23. doi: 10.1093/annonc/mdt372. Review.


Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population.

Zhou Y, Boudreau DM, Freedman AN.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):43-50. doi: 10.1002/pds.3463.


Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.

Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, Ballard-Barbash R, Doroshow JH, Minasian LM.

J Natl Cancer Inst. 2010 Nov 17;102(22):1698-705. doi: 10.1093/jnci/djq390.

Supplemental Content

Loading ...
Support Center